Recro Pharma Overview
Recro Pharma Discounted Cash Flow
DCF Analysis for REPH.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.58
Current Fair Value
$2.58
↑ 23.5% Upside
Undervalued by 23.5% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison